Fund . AMEX . IShares . USD
iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF is a fund listed on AMEX. It holds securities and files no accounts of its own, so the figures below are what it holds, what it costs and how concentrated it is. Its largest sector is Pharmaceuticals.
Market data, for 2026-11-06. Written to our own tables on 2026-10-15.
We do not hold the index this fund tracks, so its drift is not measured. It is measurable, and it is not measured yet.
What it holds
- ELI LILLY24.8%
- JOHNSON & JOHNSON21.9%
- PFIZER4.8%
- ZOETIS INC CLASS A4.7%
- MERCK & CO INC4.6%
- VIATRIS4.5%
- ROYALTY PHARMA PLC CLASS A4.5%
- BRISTOL MYERS SQUIBB4.2%
- JAZZ PHARMACEUTICALS PLC3.1%
- ELANCO ANIMAL HEALTH2.5%
- CORCEPT THERAPEUTICS2.5%
- AXSOME THERAPEUTICS1.6%
- LIGAND PHARMACEUTICALS1.3%
- DEFINIUM THERAPEUTICS INC1.0%
- INDIVIOR PHARMACEUTICALS INC0.9%
- ORGANON0.8%
- VERADERMICS0.8%
- AMNEAL PHARMACEUTICALS INC CLASS A0.8%
- EDGEWISE THERAPEUTICS0.7%
- TARSUS PHARMACEUTICALS0.6%
- AMYLYX PHARMACEUTICALS0.6%
- LIQUIDIA0.6%
- ENLIVEN THERAPEUTICS0.6%
- SUPERNUS PHARMACEUTICALS0.5%
- PRESTIGE CONSUMER HEALTHCARE0.5%
the largest 25 of 53 lines it discloses, as the fund disclosed them on 2026-10-15.
What a fund cannot have
A fund files no accounts of its own.
Earnings per share
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Return on equity
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Revenue
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
Book value per share
A fund has no accounts of its own. What it holds earns, reports and owns; the wrapper around them does not, so this figure has nothing to be measured from.
US ETFs with a page: 990, counted 2026-11-08